GILD News 105.36 09/08/2014 04:58:07 Gilead Sciences (GILD)

New Post Public Reply Private Reply Replies (0) Message Board

Sep 8, 2014 at 5:58 AM

Gilead Sciences (GILD) 105.36 $GILD

Is a Cheap Hepatitis C Cure About to Go Global?
Todd Campbell, The Motley Fool - Motley Fool - Sun Sep 07, 2:03PM CDT
Source: Gilead Sciences Last December, the FDA ushered in a new era in hepatitis C treatment when it approved Gilead Sciences ' Sovaldi -- a nucleotide analog NS5B polymerase inhibitor that simply knocks-out hepatitis C cold. In trials, 90% of...

Meet 5 IBD 50 Stocks Expanding Into New Markets
at Investor's Business Daily - Sat Sep 06, 7:01AM CDT
The IBD 50 list ranks stocks on a combination of recent profit growth and key measures such as return on equity, sales growth and profit margins, listing the strongest stocks first. Today's IBD 50 includes five companies that are expanding into new...

'Fast Money' Recap: Stocks Climb, Bonds Fall This Week
at The Street - Sat Sep 06, 4:00AM CDT
The trading panel discussed the overall market and whether to trade Chinese stocks.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Sep 05, 6:37PM CDT
Cramer is looking for bargains, and that means he'll be watching Yahoo!, Apple and Restoration Hardware next week.

Salix, Gilead Among 5 Top Medical Leaders To Watch
at Investor's Business Daily - Fri Sep 05, 4:06PM CDT
Top-performing medical stocks can be a panacea for a depressed portfolio. Today's Tech Leaders - Medical Screen features some heavy hitters in the pharmaceutical field. The maker of gastrointestinal disorder drugs such as Pepcid, Salix...

Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 4:05PM CDT
Mallinckrodt plc (MNK) announced encouraging results from a phase III efficacy study on its pain candidate, MNK-155.

Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 3:45PM CDT
Celgene's (CELG) Revlimid performed well in a late-stage study on NDMM.

Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 3:35PM CDT
Abbott Labs (ABT) received positive news when its FreeStyle Libre Flash Glucose Monitoring System obtained CE Mark (Conformite Europeenne) in Europe.

Why Gilead Sciences (GILD) Stock Is Down Today
at The Street - Fri Sep 05, 3:10PM CDT
Shares of Gilead Sciences (GILD) fell in morning trading on news it's close to a deal to bring cheaper versions of the hepatitis C drug Sovaldi to developing nations.

Most active Nasdaq-traded stocks
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:

Midday Glance: Biotechnology companies
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:

Why Gilead Is Falling On Drugs For Developing Nations
at Investor's Business Daily - Fri Sep 05, 2:15PM CDT
Shares of Gilead Sciences (GILD) are down amid news that the drugmaker is reportedly nearing a licensing deal to bring its blockbuster hepatitis C drug Sovaldi to developing countries such as India and Pakistan. Generic drugmakers would be able to...

Next Support Level for Gilead Sciences (GILD) is $103.98
Comtex SmarTrend(R) - Fri Sep 05, 12:25PM CDT
Gilead Sciences (NASDAQ:GILD) has opened bearishly below the pivot of $107.71 today and has reached the first level of support at $105.42. Analysts will be watching for a cross of the next downside pivot targets of $103.98 and $100.25.

Indexes Trim Losses But Remain Lower At Midday
at Investor's Business Daily - Fri Sep 05, 11:04AM CDT
The stock market came off morning lows at midday Friday, but remained lower as some notable leaders came under fire. The Nasdaq fell 0.3% while the S&P 500 and the Dow Jones industrial average were down 0.1%. Volume was running higher on the NYSE and...

Stocks Sag In Light Trade; Taser Bolts Higher, Gilead Dips
at Investor's Business Daily - Fri Sep 05, 9:33AM CDT
Stocks slipped into thin losses at the start of trade Friday. The Dow Jones industrial average and the S&P 500 were down 0.1% apiece. The Nasdaq hung a fraction below its starting point. The stock market today opened to weak trade, down 4% on the...

Early Glance: Biotechnology companies
AP - Fri Sep 05, 9:12AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:

XOMA Corporation (XOMA) Jumps: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 8:11AM CDT
XOMA Corporation (XOMA) was a big mover last session, as the company saw its shares rise over 6% on the day.

Nanosphere (NSPH) Slumps: NSPH Plunges 14.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 7:33AM CDT
Nanosphere, Inc. (NSPH) saw a big move last session,continuing the recent downtrend for NSPH, as the stock is now down 54.2% in the past one-month time frame.

Alkermes Completes Enrolment for Phase II ALKS 3831 Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 5:10PM CDT
Alkermes (ALKS) completed enrolling patients in a study on ALKS 3831.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONOR X9e Pro Unveils with Massive Battery Power

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...

Investor Scrutiny Intensifies Over M&A Deals at SGRY, RRC, EQT

When Insiders Seem to Benefit More Ah, mergers and acquisitions—it's the oldest tango in the business world. But today, we've got some footwork that might trip up the small fry. Halper Sadeh LLC, the investor rights bulldogs, are sniffing around Surgery Partners, Range Resources, and EQT. Their quest? To uncover whether the big dogs are playing unfairly with...

Honeywell Aerospace Faces Lawsuit After Stock Tumbles 23%

Honeywell's Bumpy Ride Rattles Investors Something's brewing over at Honeywell Aerospace, Inc. (NASDAQ:HONA) and it's not your regular cup of joe. Investors, brace yourselves, because a securities fraud class action lawsuit is stacking up against them. With shares plummeting 23.16% in a whirlwind of a market day, it's kind of hard not to get a little riled up, isn't it?...

EQS Group's Climate Goals Get SBTi Validation

EQS Group's Bold Climate Commitments The news hits like a gust of clean air — EQS Group's climate targets are now stamped with the seal of approval from the Science Based Targets initiative (SBTi). This isn't just your typical corporate green pledge: we're talking serious, validated commitments pushing for net-zero emissions by 2050. Decoding EQS Group's Impactful...

HCLTech Partners with Rapidus on Semiconductor Future

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Huntington Bank Bolsters Westside Future Fund with $1M Boost

Huntington's Commitment Goes Beyond Dollars In a world where corporations often toss out pretty phrases without the substance to back them up, Huntington Bank's $1 million shout-out to Atlanta's Westside Future Fund (WFF) speaks volumes. This ain't your run-of-the-mill PR move. It's a solid, tangible effort to help a community that's rich in history but screaming for...

EZRA Loop Fuses Human Insight and AI for Managers

Hybrid Coaching: The Future is Here If someone told me five years ago that human coaches and AI would team up to churn out better business leaders, I'd have a laugh. But here we are with EZRA Loop, an inventive mix of flesh-and-blood wisdom and algorithmic precision hitting the streets. This might seem like the latest buzzword pie in the sky to some, but there's a real...

SurgeONE's Avery Actions: Pioneering AI in Compliance

Revolutionizing Compliance with Avery Actions A brand spanking new player has stepped onto the compliance stage, and it's swinging a pretty big AI bat. SurgeONE.ai unveiled Avery Actions, an industry-first agentic AI platform that's aiming to wrangle all your compliance, cybersecurity, and data governance operations under one interoperable umbrella. It's a bold move, and...

Boar's Head Introduces Authentic Italian Ricotta

Boar's Head Brings Verona's Ricotta Stateside Imagine walking into your kitchen and finding a slice of authentic Italy sitting right there on your counter. That's what Boar's Head promises with its introduction of Italian Ricotta All Natural Cheese. It’s not just cheese; it’s a culinary passport straight from Verona, Italy, crafted using traditional techniques that...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...